3BIGS CO., LTD.

It wrapped up its 10-day business trip to Dubai, Qatar, and Abu Dhabi. It had dozens of meetings with leading researchers and professors from important bio-research institutes and universities in the Middle East, including UAE University, Khalifa University, Mohammed Bin Rashid University, Hamad Medical City, Sidra Medicine, and Interim Translational Research Institute. Every time I visit the Middle East, I feel it, but Middle Eastern countries are already preparing for the 4th and 5th industries, skipping the 3rd industry. Having traveled to dozens of countries, including the United States and Europe, to do global business, I didn't know much about the bio industry in the Middle East countries, but I think they prepared a great bio industry that far exceeded my expectations. The reason why this kind of achievement was achieved in such a short time was because of the large-scale oil money and the strong will of the government. From what I have already learned, it seems to be far ahead of Korea. This is because renowned scientists from all over the world are focusing on the bio-industry here. The size of the project is at least 10 to dozens of times larger than that of Korea. It's a pity that Korea doesn't seem to know the Middle East at all. However, I don't think we should ignore Middle Eastern countries and enter the Middle East without preparing properly. Since the world's best companies and researchers are already in place, it will not be easy without differentiation and specialization to compete with them. Since the company was founded, 3BIGS has established and operated a branch in India, advocating global business, and now it seems that it is gradually creating a way out in its seventh year. Today, I met Dr. Park Min-sung in Abu Dhabi. Dr. Park is the Chief Scientific Officer and Genomic Medicine Officer in the UAE Sanimed International Labs and Management Division & Senior Advisor in the UAE International Holding Company (IHC) Medical Division S&T, the founding director of G42 Healthcare in the UAE, and he has run Genome projects in the United States, Europe, China and the UAE. It is an honor to meet such a person, but I received a lot of advice and decided to be of great help to the Middle East business in the future. In particular, I was very happy to know that Dr. Park was from Busan, the same hometown as me, and studied at Pusan National University. I would like to thank Nadia, Faisal Al Bahar and Mohammed Osman for having many informative meetings through NeoScience during this business trip. I think the bio-big data industry in Middle East countries will be able to make a big one with NeoScience.

Dawood, the head of the bioinformation center, and Sridhar, a senior researcher, participated as sponsors in the MENA Microbiome Conference held in Qatar from September 28 to 29. We rarely attend booths at domestic conferences in Korea, but it seems that we have opened more booths in the Middle East, including Dubai, Abu Dhabi, and Qatar. No matter how good the technology is to conduct business through meetings online, it will not be easy to go beyond the offline meeting business where we can see each other face to face and shake hands and eat together. Through this conference, we were able to see firsthand that the microbiome research and market is quite large in the Middle East. Through this conference, Nadia CEO and executives and employees of NeoScience, our first Middle East partner, introduced many important customers such as Qatar, UAE, and Saudi Arabia, which is very helpful. Thank you Nadia CEO. Earlier this year, we launched only a women's Yzone microbiome diagnostic kit, which introduced the Gut and Oral microbiome diagnostic kits at this conference. Sidra Medicine, which hosted this conference, was particularly interested in our Y-zone microbiome diagnostic service as it is conducting many studies on women's health. The microbiome service app, which will be operated from October, was also installed on my smartphone and introduced it to overseas customers for the first time. Our customers in the Middle East were quite surprised by our service and suggested joint research and business to us first, which made me feel rewarded for attending this conference. Having visited several Middle Eastern countries since last year, 3BIGS seems to be gradually establishing itself as a bio big data and bioinformatics consulting firm in Middle Eastern countries. I feel once again that the center of the world is the Middle East, and I renew my commitment to open a way for Korea's difficult bio-business situation here.

Everyone knows that India is a fairly good country in IT. It is also called India's Silicon Valley, and "Bangalore" is home to 35% of India's IT professionals. That's why 3BIGS has been the first and only Korean company in the bio sector to establish and operate a branch in Bangalore since 2018. Through a visit to Garden City University in February, I learned that the old name of the city is Garden City. Yesterday, I signed an MOU with Garden City University. After visiting in February to introduce and present the company, the students are interning at 3BIGS, and they are doing so well. Among the tens of thousands of cities in the world, Bangalore is one of the 10 most rapidly growing cities in the world. In other words, Garden City University will also increase its status considerably in the future. Based on this MOU, there will be more diverse and closer cooperation between Garden City University and 3BIGS. Since the university is located in the same city, there are quite a lot of areas to cooperate. As I visited in February, I was so moved that I made Korean food and served it to a hotel restaurant run by the school as a Korean. I attended with Indian executives and team leaders who have been working together for 7 years since 2018 and shared their vision for 3BIGS. I have focused on overseas business such as Middle Eastern countries since last year, but I think I will see results one by one starting this month. Soon, you will see the 2nd round of 3BIGS.

It's been a long time since I posted this. It feels like I have to go abroad to talk about it. I was appointed as an adjunct professor at Manipal University in India in May this year, and I was selected as the first key note speaker at an international conference held today at Manipal University, and I made a presentation titled "BioAI based FemTech Platform." 50% of the world's 8 billion people are women. I presented 3BIGS's business model for health care solutions and platforms for women. In India, the largest market in the future, I'm now going to approach it as a research-based business model. I think India is a lot friendlier now.